By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Media HydeMedia Hyde
  • Home
  • Politics
  • Education
  • Entertainment
  • Sports
  • Blogs
  • Business & Commerce
  • Others
    • Religious
    • Metropolitan
    • Climate and Weather
Font ResizerAa
Media HydeMedia Hyde
Font ResizerAa
  • Home
  • Politics
  • Education
  • Entertainment
  • Sports
  • Blogs
  • Business & Commerce
  • Others
    • Religious
    • Metropolitan
    • Climate and Weather
Follow US
© 2026 Media Hyde Network. All Rights Reserved.
Health

HIV, a Deadly Disease, has Raised Alarm in Pakistan

Last updated: April 25, 2026 12:10 am
Neha Ashraf
Share
SHARE

In Pakistan, HIV is rapidly spreading from specific groups and regions into general cities and the wider population.

‎According to details, the rising number of HIV cases in Pakistan has sounded alarm bells across the country. Health experts say the deadly disease is no longer confined to specific groups but is quickly taking root among the general population and in smaller cities.

‎Reports indicate that the total number of people affected by HIV in Pakistan has reached 370,000.

‎The most alarming aspect is that 79 percent of those affected are completely unaware of their condition, unknowingly contributing to the spread of the virus. The virus is now rapidly affecting children and the general public.

‎Health experts have termed the current situation a failure of the healthcare system, stating that the use of unsafe injections and the transfusion of contaminated blood are the major causes of the spread of this disease.

‎Former Health Minister Dr Zafar Mirza has warned that the increasing number of HIV cases among children reflects serious weaknesses in the healthcare system.

‎Dr Rana Jawad Asghar said that repeated outbreaks are proof that the measures taken to control the disease are insufficient.

‎Experts have warned that if monitoring of blood banks, proper screening, and infection control are not immediately improved, the situation could turn into a major health crisis.

‎They emphasized that screening before blood transfusions must be ensured 100 percent, strict regulations on the use of disposable syringes and sterilization of medical equipment must be enforced in hospitals and clinics, and public awareness about screening and testing should be increased so that undiagnosed patients can be identified.

Share This Article
Email Copy Link Print
Previous Article Pharmacists, Psychologists and Dental Technician’s Clinical Practice Declared Illegal
Next Article Polio Drops to be Administered to Children up to 10 Years in High Risk UCs of Karachi: Mustafa Kamal ‎
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Sponsored Ads

Stay Connected

FacebookLike
XFollow
InstagramFollow
YoutubeSubscribe
WhatsAppFollow
ThreadsFollow
Epstein Housed Abuse Victims in London Flats, BBC Reveals
Court & Crime Headline
April 25, 2026
No 10 Says Falklands Sovereignty Rests with UK After Report of US ‘Review’
Headline Politics
April 25, 2026
Govt Hikes Petrol, High-Speed Diesel Prices by Rs 26
Business & Commerce Headline
April 25, 2026
Parallel Economy: How Russia Is Defying Western Sanctions Through Alternative Trade Channels
Headline international
April 25, 2026
Romania Tests AI-Powered Drone Interceptors as Ukraine War Raises Regional Security Concerns
Headline Technology
April 25, 2026
Peugeot to Build Vehicles Using Dongfeng Technology in China
Headline Technology
April 25, 2026

You Might Also Like

Health

Ziauddin University Hosts International Nursing Research Conference 2025

By
Irma Khan
WASHINGTON: UnitedHealth has warned that the Trump administration’s planned Medicare obesity-drug pilot faces “notable challenges,” casting doubt over how smoothly the program can move ahead if major insurers stay cautious. Recent market reporting said the model depends heavily on participation from Medicare drug plans that cover most Part D enrollees, which makes the stance of large insurers especially important. The concern centers on a broader CMS effort to expand access to GLP-1 weight-loss medicines for seniors. Under CMS’s published framework, the longer-term BALANCE Model would begin in Medicare Part D in January 2027, while a temporary Medicare GLP-1 Bridge is designed to start earlier and give eligible beneficiaries short-term access before that main model begins. What makes this a little more complicated is that the short-term bridge and the longer pilot are not the same thing. CMS says the Medicare GLP-1 Bridge operates outside the normal Part D coverage and payment flow, meaning Part D sponsors are not directly involved in that bridge arrangement. In other words, insurer participation is a much bigger issue for the 2027 BALANCE rollout than for the bridge itself. That distinction matters because investors and drugmakers are watching this closely. Reports said shares of obesity-drug makers fell after UnitedHealth’s comments, largely because Medicare coverage is seen as a huge growth opportunity for drugs such as Wegovy and Zepbound. If major insurers hesitate, the program could struggle to achieve the scale CMS appears to want. There is already some evidence of resistance. MarketWatch reported that CVS Health has opted out, while UnitedHealth is still evaluating the structure and discussing possible changes with Medicare officials. That does not mean the program is dead, not yet anyway, but it does suggest the administration may need to revise the design or sweeten the terms if it wants broader insurer buy-in. The bigger backdrop here is cost. Medicare has long been wary of broad obesity-drug coverage because GLP-1 therapies are expensive and potentially involve very large patient populations. Earlier policy debates around these drugs were shaped by concerns that wide coverage could drive up federal spending sharply, even as supporters argued the medicines could reduce longer-term health costs tied to obesity. So the headline problem for CMS is pretty straightforward: it has created a short-term bridge that can move without direct Part D plan involvement, but the more ambitious long-term Medicare model still appears to need insurers on board. UnitedHealth’s warning does not shut the door, but it does signal that one of the industry’s biggest players thinks the current setup may not be ready for easy launch.
HeadlineHealth

UnitedHealth raises red flags over Medicare obesity-drug pilot

By
Mabruka Khan
Health

Government Decides On Effective Monitoring Of The Pharmaceutical Industry

By
Neha Ashraf
Health

Punjab launches “Clinics on Boats” in flood hit areas

By
Neha Ashraf
Media Hyde Media Hyde Dark
Facebook Twitter Youtube Rss Medium

About US

Media Hyde Network: Your instant connection to breaking stories and live updates. Stay informed with our real-time coverage across politics, tech, entertainment, and more. Your reliable source for 24/7 News.

Top Categories
  • Headline
  • Politics
  • Entertainment
  • Education
  • Sports
  • Religious
  • Metropolitan
  • Climate and Weather
Usefull Links
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Cookies Policy
  • Advertising Policy
  • Terms & Conditions

© 2025 Media Hyde Network. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?